Pharmacological Correlation between Total Drug Concentration and Lactones of CPT‐11 and SN‐38 in Patients Treated with CPT‐11

por Sasaki, Yasutsuna, Yoshida, Yasushi, Sudoh, Kenichi, Hakusui, Hideo, Fujii, Hirofumi, Ohtsu, Tomoko, Wakita, Hisashi, Igarashi, Tadahiko, Itoh, Kuniaki
Publicado 1995

A Limited Sampling Model for Estimating Pharmacokinetics of CPT‐11 and Its Metabolite SN‐38

por Sasaki, Yasutsuna, Mizuno, Shoichi, Fujii, Hirofumi, Ohtsu, Tomoko, Wakita, Hisashi, Igarashi, Tadahiko, Itoh, Kuniaki, Sekine, Ikuo, Miyata, Yoshinori, Saijo, Nagahiro
Publicado 1995

Treatable Subsets in Cancer of Unknown Primary Origin

por Sumi, Hajime, Itoh, Kuniaki, Onozawa, Yusuke, Shigeoka, Yasushi, Kodama, Keiji, Ishizawa, Kenichi, Fujii, Hirofumi, Minami, Hironobu, Igarashi, Tadahiko, Sasaki, Yasutsuna
Publicado 2001

Phase I Study of Intravenous PSC‐833 and Doxorubicin: Reversal of Multidrug Resistance

por Minami, Hironobu, Ohtsu, Tomoko, Fujii, Hirofumi, Igarashi, Tadahiko, Itoh, Kuniaki, Uchiyama‐Kokubu, Noriko, Aizawa, Tetsushi, Watanabe, Torn, Uda, Yoshinori, Tanigawara, Yusuke, Sasaki, Yasutsuna
Publicado 2001

Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic‐phase chronic myeloid leukemia based on early achievement of deep molecular response (MR(4.5)):...

por Nishiwaki, Kaichi, Sugimoto, Kei‐ji, Tamaki, Shigehisa, Hisatake, Junichi, Yokoyama, Hisayuki, Igarashi, Tadahiko, Shinagawa, Atsushi, Sugawara, Takeaki, Hara, Satoru, Fujikawa, Kazuhisa, Shimizu, Seiichi, Yujiri, Toshiaki, Tojo, Arinobu, Wakita, Hisashi
Publicado 2020

Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T‐cell lymphoma

por Kawai, Hidetsugu, Ando, Kiyoshi, Maruyama, Dai, Yamamoto, Kazuhito, Kiyohara, Eiji, Terui, Yasuhito, Fukuhara, Noriko, Miyagaki, Tomomitsu, Tokura, Yoshiki, Sakata‐Yanagimoto, Mamiko, Igarashi, Tadahiko, Kuroda, Junya, Fujita, Jiro, Uchida, Toshiki, Ishikawa, Takayuki, Yonekura, Kentaro, Kato, Koji, Nakanishi, Tadashi, Nakai, Kenya, Matsunaga, Risa, Tobinai, Kensei
Publicado 2021

Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response

por Okamoto, Yuji, Hirano, Mitsuhito, Morino, Kai, Kajita, Masashi K., Nakaoka, Shinji, Tsuda, Mayuko, Sugimoto, Kei-ji, Tamaki, Shigehisa, Hisatake, Junichi, Yokoyama, Hisayuki, Igarashi, Tadahiko, Shinagawa, Atsushi, Sugawara, Takeaki, Hara, Satoru, Fujikawa, Kazuhisa, Shimizu, Seiichi, Yujiri, Toshiaki, Wakita, Hisashi, Nishiwaki, Kaichi, Tojo, Arinobu, Aihara, Kazuyuki
Publicado 2022

DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study

por Miyazaki, Kana, Asano, Naoko, Yamada, Tomomi, Miyawaki, Kohta, Sakai, Rika, Igarashi, Tadahiko, Nishikori, Momoko, Ohata, Kinya, Sunami, Kazutaka, Yoshida, Isao, Yamamoto, Go, Takahashi, Naoki, Okamoto, Masataka, Yano, Hiroki, Nishimura, Yuki, Tamaru, Satoshi, Nishikawa, Masakatsu, Izutsu, Koji, Kinoshita, Tomohiro, Suzumiya, Junji, Ohshima, Koichi, Kato, Koji, Katayama, Naoyuki, Yamaguchi, Motoko
Publicado 2019

Prophylactic antiviral therapy for hepatitis B virus surface antigen‐positive patients with diffuse large B‐cell lymphoma treated with rituximab‐containing chemotherapy

por Yamauchi, Nobuhiko, Maruyama, Dai, Choi, Ilseung, Atsuta, Yoshiko, Sakai, Rika, Miyashita, Kazuho, Moriuchi, Yukiyoshi, Tsujimura, Hideki, Kubota, Nobuko, Yamamoto, Go, Igarashi, Tadahiko, Izutsu, Koji, Yoshida, Shinichiro, Kojima, Kensuke, Uchida, Toshiki, Inoue, Yoshiko, Tsukamoto, Norifumi, Ohtsuka, Eiichi, Suzuki, Sachiko, Inaguma, Yoko, Ichikawa, Satoshi, Gomyo, Hiroshi, Ushijima, Yoko, Nosaka, Kisato, Kurata, Mio, Tanaka, Yasuhito, Ueda, Ryuzo, Mizokami, Masashi, Kusumoto, Shigeru
Publicado 2021